Avistone Announces Preclinical Results for ANS03, a Novel Type II ROS1/NTRK Inhibitor in Overcomi...

Avistone Announces Preclinical Results for ANS03, a Novel Type II ROS1/NTRK Inhibitor in Overcoming Clinically Relevant ROS1/NTRK Resistance Mutations at AACR Annual Meeting 2025  BioSpace

Utility of Digital Twin AI-Generated Models to Improve Patient Selection in Alzheimer Trials - Ne...

Utility of Digital Twin AI-Generated Models to Improve Patient Selection in Alzheimer Trials  NeurologyLive

The FDA Has Cleared the First Clinical Trial Application for a Prime Editor - CRISPR Medicine News

The FDA Has Cleared the First Clinical Trial Application for a Prime Editor  CRISPR Medicine News

Coronavirus: first person injected with trial vaccine - Al Jazeera

Coronavirus: first person injected with trial vaccine  Al Jazeera

Compass plans IPO to take 'magic mushroom' drug to phase 3 - Fierce Biotech

Compass plans IPO to take 'magic mushroom' drug to phase 3  Fierce Biotech

“Solidarity” clinical trial for COVID-19 treatments - World Health Organization (WHO)

“Solidarity” clinical trial for COVID-19 treatments  World Health Organization (WHO)

Biological, clinical, and ethical advances of placebo effects - The Lancet

Biological, clinical, and ethical advances of placebo effects  The Lancet

Clara Health launches initiative to match patients to COVID-19 clinical trials - Fierce Healthcare

Clara Health launches initiative to match patients to COVID-19 clinical trials  Fierce Healthcare

Adjunctive antimicrobial chemotherapy based on hydrogen peroxide photolysis for non-surgical trea...

Adjunctive antimicrobial chemotherapy based on hydrogen peroxide photolysis for non-surgical treatment of moderate to severe periodontitis: a randomized controlled trial  Nature

「やせ薬」市場参入の難しさ示唆、ファイザー今年２度目の開発中止 - Bloomberg.com

「やせ薬」市場参入の難しさ示唆、ファイザー今年２度目の開発中止  Bloomberg.com